OrthoSpace Ltd., Caesarea, Israel-based medical device company, completed a financing of undisclosed amount.
The round was led by HealthpointCapital with participation from existing investors Smith & Nephew and TriVentures.
The proceeds will facilitate the company’s continued market adoption, clinical study programs and entry into the emerging markets.
Led by CEO Itay Barnea and Co-Founder and Medical Director Assaf Dekel MD, OrthoSpace provides InSpace, a an orthopedic biodegradable balloon system for the treatment of severe rotator cuff tears.
It is CE Marked and commercialized in Europe and Israel and has been granted an Investigational Device Exemption (IDE) to initiate a pivotal human clinical study of the system in the United States.